Sorafenib The ‘New Standard’ for Advanced Liver Cancer
REFERENCE: ABSTRACT 5 (Plenary Session), ASCO Annual Meeting Chicago June 1-5, 2007 JOSEP LLOVET, IDIBAPS Hospital Clinic, Barcelona, and Mount Sinai School of Medicine, New York COMMENT: ROBERT
Bevacizumab in Advanced Kidney Cancer: Another Treatment Gives Benefit in First Line
REFERENCE: ABSTRACT 3, ASCO Annual Meeting Chicago June 1-5, 2007 BERNARD ESCUDIER, Gustave Roussy Institute, Villejuif COMMENT: DEAN BAJORIN, Memorial Sloan-Kettering Cancer Center, New
